The GIMM Festival convened international researchers, clinicians, and stakeholders to identify priority research questions that should guide the aging and longevity field forward. The consensus-driven approach produced a shared roadmap addressing scientific gaps, clinical translation, and societal implications of aging research.
Key Points
- Multidisciplinary collaboration defines the next research frontier in aging science
- Clinical translation remains underaddressed relative to mechanistic aging discoveries
- Societal integration of longevity science requires broader stakeholder engagement
Longevity Analysis
The consolidation of research priorities across disciplines addresses a critical infrastructure gap in the aging field: the disconnect between what we understand mechanistically about aging and what we actually implement clinically. When research questions lack alignment across basic science, medicine, and implementation, resources fragment and therapeutic advances stall at the bench. This roadmap-building approach recognizes that the limiting factor in human longevity optimization is no longer solely our understanding of aging biology—it is our capacity to translate that knowledge into sustainable, scalable interventions that address both individual health span and population-level aging patterns. The inclusion of artists and civil society signals recognition that behavior change, cultural adoption, and ethical frameworks determine whether aging science becomes integrated into medical practice or remains siloed in research institutions.
Original published by Nature Aging, by Laura Ward.